Verrica Parmaceuticals Inc (VRCA)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current VRCA market cap is 78.08M. The company's latest EPS is USD -1.5701 and P/E is -1.18.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 182k | 2.92M | 1.99M | 3.83M | 5.18M |
| Operating Income | -11.62M | -23.92M | -23M | -18.6M | -15.21M |
| Net Income | -10.99M | -24.8M | -24.61M | -20.33M | -17.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 12M | 9.03M | 5.12M |
| Operating Income | -30.08M | -40.18M | -30.91M | -21.3M | -63.22M |
| Net Income | -28.21M | -42.69M | -35.08M | -24.49M | -67M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 62.2M | 97.15M | 81.6M | 66.31M | 52.01M |
| Total Liabilities | 6.8M | 54.85M | 61.83M | 64.8M | 65.31M |
| Total Equity | 55.4M | 42.3M | 19.76M | 1.51M | -13.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 68.42M | 74.15M | 80.13M | 44.72M | 81.6M |
| Total Liabilities | 3.41M | 41.17M | 47.52M | 4.69M | 61.83M |
| Total Equity | 65.02M | 32.99M | 32.61M | 40.03M | 19.76M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.26M | -24.07M | -38.58M | -19.95M | -36.31M |
| Investing | -70k | -135k | -362k | N/A | -11k |
| Financing | 30.2M | 74.24M | 74.21M | -661k | -1.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -27.41M | -30.21M | -27.58M | -18.65M | -38.58M |
| Investing | 25.96M | -3.58M | -998k | 54.04M | -362k |
| Financing | 423k | 35.23M | 33.65M | -16.87M | 74.21M |
| Market Cap | 78.08M |
| Price to Earnings Ratio | -1.18 |
| Price to Sales Ratio | 15.4 |
| Price to Cash Ratio | 1.14 |
| Price to Book Ratio | 3.99 |
| Dividend Yield | - |
| Shares Outstanding | 42.67M |
| Average Volume (1 week) | 459.14k |
| Average Volume (1 Month) | 1.01M |
| 52 Week Change | -54.70% |
| 52 Week High | 11.41 |
| 52 Week Low | 1.77 |
| Spread (Intraday) | 0.01 (0.54%) |
| Company Name | Verrica Parmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.verrica.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
